RO
REVO Oncology Diagnostics Inc.
SEC filingOther Health Care · Frisco, TX
Amount raised$270Ksold at filing
Total offering$1.2M$930K still open
Investors in the raise7count reported to the SEC
FiledApr 13, 2026first sale Sep 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Estevan KiernanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.